CivaTech Oncology:Feasibility study to treat lung cancer with the permanently implantable LDR CivaSheet

Go Back to All Clinical Trials

CivaTech Oncology:Feasibility study to treat lung cancer with the permanently implantable LDR CivaSheet

Brief description of study

This is a feasibility study to determine the usefulness of a brachytherapy device that utilizes active components (palladium-103) of standard devices in a novel configuration, which may benefit lung cancer patients by reducing the radiation dose to critical structures, such as the heart wall, while giving a therapeutic dose to diseased tissue, such as at a surgical margin

Clinical Study Identifier: s17-01418

ClinicalTrials.gov Identifier: NCT03290534

Principal Investigator: Michael Zervos.

Other Investigators: Beverly E Smith, Harvey I Pass, Robert J. Cerfolio, Stephanie H. Chang, Benjamin Cooper, Costas Bizekis.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Perlmutter Cancer Center

Clinical Trials & Research Studies